MDT

SEC source: 0001613103-24-000111 · wk-form4_1722982277.xml · nonDerivative · entry 1

Fong Ivan K · CIK 0001342238 · EVP GENERAL COUNSEL & SECR

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,029

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares issued upon the settlement of performance-vesting restricted stock units granted on February 1, 2022 and earned dividend equivalents.

SEC source: 0001613103-24-000115 · wk-form4_1722982417.xml · derivative · entry 8

PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Performance Share Units · 7,132 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock.

F6 · derivative.exercise_date: The performance share units vested on August 2, 2024.

F6 · derivative.expiration_date: The performance share units vested on August 2, 2024.

SEC source: 0001613103-24-000115 · wk-form4_1722982417.xml · nonDerivative · entry 3

PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,730

F3 · shares: Represents shares withheld for taxes upon the vesting of restricted stock units previously reported on Table I.

SEC source: 0001613103-24-000115 · wk-form4_1722982417.xml · nonDerivative · entry 2

PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,311

F2 · shares: Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units that vested on August 2, 2024.

SEC source: 0001613103-24-000115 · wk-form4_1722982417.xml · nonDerivative · entry 1

PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,459

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares issued upon the settlement of performance-vesting restricted stock units granted on August 2, 2021 and earned dividend equivalents.

SEC source: 0001613103-24-000117 · wk-form4_1722982483.xml · derivative · entry 4

Smith Gregory L · CIK 0001533098 · EVP Global Ops & Supply Chain

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Performance Share Units · 3,490 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock.

F5 · derivative.exercise_date: The performance share units vested on August 2, 2024.

F5 · derivative.expiration_date: The performance share units vested on August 2, 2024.

SEC source: 0001613103-24-000117 · wk-form4_1722982483.xml · nonDerivative · entry 3

Smith Gregory L · CIK 0001533098 · EVP Global Ops & Supply Chain

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,870

F3 · shares: Represents shares withheld for taxes upon the vesting of restricted stock units previously reported on Table I.

SEC source: 0001613103-24-000117 · wk-form4_1722982483.xml · nonDerivative · entry 2

Smith Gregory L · CIK 0001533098 · EVP Global Ops & Supply Chain

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,383

F2 · shares: Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units that vested on August 2, 2024.

SEC source: 0001613103-24-000117 · wk-form4_1722982483.xml · nonDerivative · entry 1

Smith Gregory L · CIK 0001533098 · EVP Global Ops & Supply Chain

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 64,757

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares issued upon the settlement of performance-vesting restricted stock units granted on August 2, 2021 and earned dividend equivalents.

SEC source: 0001613103-24-000114 · wk-form4_1722982387.xml · derivative · entry 4

Martha Geoffrey · CIK 0001560409 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Performance Share Units · 18,966 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock.

F5 · derivative.exercise_date: The performance share units vested on August 2, 2024.

F5 · derivative.expiration_date: The performance share units vested on August 2, 2024.

SEC source: 0001613103-24-000114 · wk-form4_1722982387.xml · nonDerivative · entry 3

Martha Geoffrey · CIK 0001560409 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 184,914

F3 · shares: Represents shares withheld for taxes upon the vesting of restricted stock units previously reported on Table I.

SEC source: 0001613103-24-000114 · wk-form4_1722982387.xml · nonDerivative · entry 2

Martha Geoffrey · CIK 0001560409 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 194,437

F2 · shares: Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units that vested on August 2, 2024.

SEC source: 0001613103-24-000114 · wk-form4_1722982387.xml · nonDerivative · entry 1

Martha Geoffrey · CIK 0001560409 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 203,086

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares issued upon the settlement of performance-vesting restricted stock units granted on August 2, 2021 and earned dividend equivalents.

SEC source: 0001613103-24-000116 · wk-form4_1722982456.xml · derivative · entry 4

Salmon Sean · CIK 0001792380 · EVP & President Cardiovascular

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Performance Share Units · 5,462 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock.

F5 · derivative.exercise_date: The performance share units vested on August 2, 2024.

F5 · derivative.expiration_date: The performance share units vested on August 2, 2024.

SEC source: 0001613103-24-000116 · wk-form4_1722982456.xml · nonDerivative · entry 3

Salmon Sean · CIK 0001792380 · EVP & President Cardiovascular

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,110

F3 · shares: Represents shares withheld for taxes upon the vesting of restricted stock units previously reported on Table I.

SEC source: 0001613103-24-000116 · wk-form4_1722982456.xml · nonDerivative · entry 2

Salmon Sean · CIK 0001792380 · EVP & President Cardiovascular

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,889

F2 · shares: Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units that vested on August 2, 2024.

SEC source: 0001613103-24-000116 · wk-form4_1722982456.xml · nonDerivative · entry 1

Salmon Sean · CIK 0001792380 · EVP & President Cardiovascular

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,546

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares issued upon the settlement of performance-vesting restricted stock units granted on August 2, 2021 and earned dividend equivalents, of which 4,369 shares will be delivered to the reporting person when his employment with the Company ends.

SEC source: 0001613103-24-000113 · wk-form4_1722982358.xml · derivative · entry 4

Marinaro Michael · CIK 0001984186 · EVP & President, Surgical OU

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Performance Share Units · 1,670 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock.

F5 · derivative.exercise_date: The performance share units vested on August 2, 2024.

F5 · derivative.expiration_date: The performance share units vested on August 2, 2024.

SEC source: 0001613103-24-000113 · wk-form4_1722982358.xml · nonDerivative · entry 3

Marinaro Michael · CIK 0001984186 · EVP & President, Surgical OU

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,391

F3 · shares: Represents shares withheld for taxes upon the vesting of restricted stock units previously reported on Table I.

SEC source: 0001613103-24-000113 · wk-form4_1722982358.xml · nonDerivative · entry 2

Marinaro Michael · CIK 0001984186 · EVP & President, Surgical OU

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,238

F2 · shares: Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units that vested on August 2, 2024.

SEC source: 0001613103-24-000113 · wk-form4_1722982358.xml · nonDerivative · entry 1

Marinaro Michael · CIK 0001984186 · EVP & President, Surgical OU

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,801

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares issued upon the settlement of performance-vesting restricted stock units granted on August 2, 2021 and earned dividend equivalents.

SEC source: 0001613103-24-000112 · wk-form4_1722982328.xml · derivative · entry 4

Kirk Jennifer M · CIK 0001613343 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Performance Share Units · 1,138 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock.

F5 · derivative.exercise_date: The performance share units vested on August 2, 2024.

F5 · derivative.expiration_date: The performance share units vested on August 2, 2024.

SEC source: 0001613103-24-000112 · wk-form4_1722982328.xml · nonDerivative · entry 3

Kirk Jennifer M · CIK 0001613343 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,504

F3 · shares: Represents shares withheld for taxes upon the vesting of restricted stock units previously reported on Table I.

SEC source: 0001613103-24-000112 · wk-form4_1722982328.xml · nonDerivative · entry 2

Kirk Jennifer M · CIK 0001613343 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,888

F2 · shares: Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units that vested on August 2, 2024.

SEC source: 0001613103-24-000112 · wk-form4_1722982328.xml · nonDerivative · entry 1

Kirk Jennifer M · CIK 0001613343 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,980

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares issued upon the settlement of performance-vesting restricted stock units granted on August 2, 2021 and earned dividend equivalents, of which 910 shares will be delivered to the reporting person when her employment with the Company ends.

SEC source: 0001613103-24-000100 · wk-form4_1722617283.xml · nonDerivative · entry 1

Smith Gregory L · CIK 0001533098 · EVP Global Ops & Supply Chain

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,267

F1 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I.

SEC source: 0001613103-24-000098 · wk-form4_1722471023.xml · derivative · entry 3

Walter Matthew R. · CIK 0002028475 · SVP, Chief HR Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,364

Underlying: Ordinary Shares · 56,364 shares

Expires 2034-07-29

F5 · derivative.exercise_date: These options became exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.

SEC source: 0001613103-24-000098 · wk-form4_1722471023.xml · derivative · entry 2

Walter Matthew R. · CIK 0002028475 · SVP, Chief HR Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,063

Underlying: Performance Share Units · 19,063 shares

Expires not disclosed

F2 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock.

F3 · derivative.exercise_date: Vests on July 29, 2027.

F3 · derivative.expiration_date: Vests on July 29, 2027.

F4 · derivative.underlying_shares: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 19,063 shares will be issued. If maximum performance metrics are achieved, 38,126 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.

SEC source: 0001613103-24-000098 · wk-form4_1722471023.xml · nonDerivative · entry 1

Walter Matthew R. · CIK 0002028475 · SVP, Chief HR Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,205

F1 · shares: The restrictions on the award shall lapse 100% on the third anniversary of the Grant Date.

SEC source: 0001613103-24-000096 · wk-form4_1722470893.xml · derivative · entry 3

Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 106,260

Underlying: Ordinary Shares · 106,260 shares

Expires 2034-07-29

F6 · derivative.exercise_date: These options became exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.

SEC source: 0001613103-24-000096 · wk-form4_1722470893.xml · derivative · entry 2

Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,938

Underlying: Performance Share Units · 35,938 shares

Expires not disclosed

F3 · derivative.exercise_price: Each performance share unit represented a contingent right to receive one share of Medtronic common stock.

F4 · derivative.exercise_date: Vests on July 29, 2027.

F4 · derivative.expiration_date: Vests on July 29, 2027.

F5 · derivative.underlying_shares: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 35,983 shares will be issued. If maximum performance metrics are achieved, 71,876 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.

SEC source: 0001613103-24-000096 · wk-form4_1722470893.xml · nonDerivative · entry 1

Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,858

F1 · shares: The restrictions on the award shall lapse 100% on the third anniversary of the Grant Date.

F2 · balance_after: Includes 573 shares acquired through dividend reinvestment since the last report filed by the reporting person.

SEC source: 0001613103-24-000086 · wk-form4_1722470338.xml · derivative · entry 3

Fong Ivan K · CIK 0001342238 · EVP GENERAL COUNSEL & SECR

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,248

Underlying: Ordinary Shares · 94,248 shares

Expires 2034-07-29

F6 · derivative.exercise_date: These options became exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.

SEC source: 0001613103-24-000086 · wk-form4_1722470338.xml · derivative · entry 2

Fong Ivan K · CIK 0001342238 · EVP GENERAL COUNSEL & SECR

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,875

Underlying: Performance Share Units · 31,875 shares

Expires not disclosed

F3 · derivative.exercise_price: Each performance share unit represented a contingent right to receive one share of Medtronic common stock.

F4 · derivative.exercise_date: Vests July 29, 2027.

F4 · derivative.expiration_date: Vests July 29, 2027.

F5 · derivative.underlying_shares: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 31,875 shares will be issued. If maximum performance metrics are achieved, 63,750 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.

SEC source: 0001613103-24-000086 · wk-form4_1722470338.xml · nonDerivative · entry 1

Fong Ivan K · CIK 0001342238 · EVP GENERAL COUNSEL & SECR

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,659

F1 · shares: The restrictions on the award shall lapse 100% on the third anniversary of the Grant Date.

F2 · balance_after: Includes 708 shares acquired through dividend reinvestment since the last report filed by the reporting person.

SEC source: 0001613103-24-000094 · wk-form4_1722470751.xml · derivative · entry 3

Smith Gregory L · CIK 0001533098 · EVP Global Ops & Supply Chain

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 106,260

Underlying: Ordinary Shares · 106,260 shares

Expires 2034-07-29

F6 · derivative.exercise_date: These options became exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.

SEC source: 0001613103-24-000094 · wk-form4_1722470751.xml · derivative · entry 2

Smith Gregory L · CIK 0001533098 · EVP Global Ops & Supply Chain

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,938

Underlying: Performance Share Units · 35,938 shares

Expires not disclosed

F3 · derivative.exercise_price: Each performance share unit represented a contingent right to receive one share of Medtronic common stock.

F4 · derivative.exercise_date: Vests on July 29, 2027.

F4 · derivative.expiration_date: Vests on July 29, 2027.

F5 · derivative.underlying_shares: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 35,938 shares will be issued. If maximum performance metrics are achieved, 71,876 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.

SEC source: 0001613103-24-000094 · wk-form4_1722470751.xml · nonDerivative · entry 1

Smith Gregory L · CIK 0001533098 · EVP Global Ops & Supply Chain

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,673

F1 · shares: The restrictions on the award shall lapse 100% on the third anniversary of the Grant Date.

F2 · balance_after: Includes 1,268 shares acquired through dividend reinvestment and 307 shares acquired under Medtronic's Employee Stock Ownership Plan since the last report filed by the reporting person.

SEC source: 0001613103-24-000090 · wk-form4_1722470548.xml · derivative · entry 3

Martha Geoffrey · CIK 0001560409 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 295,680

Underlying: Ordinary Shares · 295,680 shares

Expires 2034-07-29

F6 · derivative.exercise_date: These options became exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.

SEC source: 0001613103-24-000090 · wk-form4_1722470548.xml · derivative · entry 2

Martha Geoffrey · CIK 0001560409 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Performance Share Units · 100,000 shares

Expires not disclosed

F3 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock.

F4 · derivative.exercise_date: Vests on July 29, 2027.

F4 · derivative.expiration_date: Vests on July 29, 2027.

F5 · derivative.underlying_shares: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 100,000 shares will be issued. If maximum performance metrics are achieved, 200,000 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.

SEC source: 0001613103-24-000090 · wk-form4_1722470548.xml · nonDerivative · entry 1

Martha Geoffrey · CIK 0001560409 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 184,120

F1 · shares: The restrictions on the award shall lapse 100% on the third anniversary of the Grant Date.

F2 · balance_after: Includes 772 shares acquired through dividend reinvestment since the last report filed by the reporting person.

SEC source: 0001613103-24-000092 · wk-form4_1722470630.xml · derivative · entry 3

Salmon Sean · CIK 0001792380 · EVP & President Cardiovascular

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 106,260

Underlying: Ordinary Shares · 106,260 shares

Expires 2034-07-29

F6 · derivative.exercise_date: These options became exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.

SEC source: 0001613103-24-000092 · wk-form4_1722470630.xml · derivative · entry 2

Salmon Sean · CIK 0001792380 · EVP & President Cardiovascular

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,938

Underlying: Performance Share Units · 35,938 shares

Expires not disclosed

F3 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock.

F4 · derivative.exercise_date: Vests on July 29, 2027.

F4 · derivative.expiration_date: Vests on July 29, 2027.

F5 · derivative.underlying_shares: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 35,938 shares will be issued. If maximum performance metrics are achieved, 71,876 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.

SEC source: 0001613103-24-000092 · wk-form4_1722470630.xml · nonDerivative · entry 1

Salmon Sean · CIK 0001792380 · EVP & President Cardiovascular

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,084

F1 · shares: The restrictions on the award shall lapse 100% on the third anniversary of the Grant Date.

F2 · balance_after: Includes 420 shares acquired through dividend reinvestment since the last report filed by the reporting person.

SEC source: 0001613103-24-000088 · wk-form4_1722470464.xml · derivative · entry 3

Marinaro Michael · CIK 0001984186 · EVP & President, Surgical OU

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 101,640

Underlying: Ordinary Shares · 101,640 shares

Expires 2034-07-29

F6 · derivative.exercise_date: These options became exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.

SEC source: 0001613103-24-000088 · wk-form4_1722470464.xml · derivative · entry 2

Marinaro Michael · CIK 0001984186 · EVP & President, Surgical OU

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,375

Underlying: Performance Share Units · 34,375 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock.

F4 · derivative.exercise_date: Vests on July 29, 2027.

F4 · derivative.expiration_date: Vests on July 29, 2027.

F5 · derivative.underlying_shares: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 34,375 shares will be issued. If maximum performance metrics are achieved, 68,750 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.

SEC source: 0001613103-24-000088 · wk-form4_1722470464.xml · nonDerivative · entry 1

Marinaro Michael · CIK 0001984186 · EVP & President, Surgical OU

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,131

F1 · shares: The restrictions on the award shall lapse 100% on the third anniversary of the Grant Date.

F2 · balance_after: Includes 456 shares acquired through dividend reinvestment since the last report filed by the reporting person.

SEC source: 0001613103-24-000084 · wk-form4_1722470162.xml · derivative · entry 5

Kirk Jennifer M · CIK 0001613343 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,540

Underlying: Ordinary Shares · 1,540 shares

Expires 2034-07-29

F8 · derivative.exercise_date: These options became exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.

SEC source: 0001613103-24-000084 · wk-form4_1722470162.xml · derivative · entry 4

Kirk Jennifer M · CIK 0001613343 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,125

Underlying: Performance Share Units · 3,125 shares

Expires not disclosed

F4 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock.

F7 · derivative.exercise_date: Vests on December 6, 2026.

F7 · derivative.expiration_date: Vests on December 6, 2026.

SEC source: 0001613103-24-000084 · wk-form4_1722470162.xml · derivative · entry 3

Kirk Jennifer M · CIK 0001613343 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,813

Underlying: Performance Share Units · 7,813 shares

Expires not disclosed

F4 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock.

F5 · derivative.exercise_date: Vests on July 29, 2027.

F5 · derivative.expiration_date: Vests on July 29, 2027.

F6 · derivative.underlying_shares: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 7,813 shares will be issued. If maximum performance metrics are achieved, 15,626 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.